Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2014, Article ID 624143, 4 pages
http://dx.doi.org/10.1155/2014/624143
Clinical Study

The Influence of the Coexpression of CD4 and CD8 in Cutaneous Lesions on Prognosis of Mycosis Fungoides: A Preliminary Study

1Institute of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Piazza Ospedale 1, 34100 Trieste, Italy
2Institute of Dermatology, Department of Experimental and Clinical Medicine, University of Udine, Ospedale San Michele, Piazza Rodolone 1, 33013 Gemona del Friuli, Italy

Received 5 May 2014; Revised 29 June 2014; Accepted 13 July 2014; Published 20 July 2014

Academic Editor: Iris Zalaudek

Copyright © 2014 Sergio Umberto De Marchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Willemze, E. S. Jaffe, G. Burg et al., “WHO-EORTC classification for cutaneous lymphomas,” Blood, vol. 105, no. 10, pp. 3768–3785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Lorincz, “Cutaneous T-cell lymphoma (mycosis fungoides),” The Lancet, vol. 347, no. 9005, pp. 871–876, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. H. S. Zackheim, S. Amin, M. Kashani-Sabet, and A. McMillan, “Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients,” Journal of the American Academy of Dermatology, vol. 40, no. 3, pp. 418–425, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. H. Kim, H. L. Liu, S. Mraz-Gernhard, A. Varghese, and R. T. Hoppe, “Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression,” Archives of Dermatology, vol. 139, no. 7, pp. 857–866, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Sausville, J. L. Eddy, R. W. Makuch et al., “Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups,” Annals of Internal Medicine, vol. 109, no. 5, pp. 372–382, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Tosca, A. G. Varelzidis, J. Economidou, and J. D. Stratigos, “Mycosis fungoides: evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages,” Journal of the American Academy of Dermatology, vol. 15, no. 2, pp. 237–245, 1986. View at Publisher · View at Google Scholar · View at Scopus
  7. C. F. Knapp, R. Mathew, J. L. Messina, and M. H. Lien, “CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant,” The American Journal of Dermatopathology, vol. 34, no. 3, pp. e37–e39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Tournier, C. Laurent, M. Thomas et al., “Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile,” Journal of Cutaneous Pathology, vol. 41, pp. 58–62, 2014. View at Google Scholar
  9. S. I. Lamberg, S. B. Green, D. P. Byar et al., “Clinical staging for cutaneous T cell lymphoma,” Annals of Internal Medicine, vol. 100, no. 2, pp. 187–192, 1984. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Guitart, J. Kennedy, S. Ronan, J. S. Chmiel, Y. Hsiegh, and D. Variakojis, “Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting,” Journal of Cutaneous Pathology, vol. 28, no. 4, pp. 174–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Miertusova Tothova, S. Bonin, G. Trevisan, and G. Stanta, “Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?” British Journal of Cancer, vol. 94, no. 6, pp. 879–883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Massone, G. Crisman, H. Kerl, and L. Cerroni, “The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality,” British Journal of Dermatology, vol. 159, no. 4, pp. 881–886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Ortolani, Flow Cytometry of Hematological Malignancies, Wiley-Blackwell, Hoboken, NJ, USA, 2011.
  14. E. T. Yanagihara, J. W. Parker, P. R. Meyer, M. J. Cain, F. Hofman, and R. J. Lukes, “Mycosis fungoides, Sezary's syndrome progressing to immunoblastic sarcoma: a T-cell lymphoproliferation with both helper and suppressor phenotypes,” The American Journal of Clinical Pathology, vol. 81, no. 2, pp. 249–257, 1984. View at Google Scholar · View at Scopus
  15. T. Nagatani, S. Kim, N. Baba et al., “Phenotypic heterogeneity of lymphoma of the skin,” The Journal of Dermatology, vol. 16, no. 6, pp. 443–452, 1989. View at Google Scholar · View at Scopus
  16. R. T. Hoppe, L. J. Medeiros, R. A. Warnke, and G. S. Wood, “CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides,” Journal of the American Academy of Dermatology, vol. 32, no. 3, pp. 448–453, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. G. S. Wood, A. Edinger, R. T. Hoppe, and R. A. Warnke, “Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype,” Journal of Cutaneous Pathology, vol. 21, no. 2, pp. 151–156, 1994. View at Publisher · View at Google Scholar · View at Scopus